Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2016 Filed Feb 13, 2017 18:43 UTC |
Reddy Sabita C.Vice President - Accounting
|
Tax withholdingCommon Stock | 49 | $11.10 | $543.90 |
DisclosureSEC source: 0001209191-17-009891 · doc4.xml · nonDerivative · entry 1 Reddy Sabita C. · CIK 0001577514 · Vice President - Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,433 F1 · shares: Shares withheld to satisfy tax obligations on vesting of restricted stock units. Read SEC document |
| February 09, 2016 Filed Nov 9, 2016 20:22 UTC |
Squires Richard D.Director
|
GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0001209191-16-149032 · doc4.xml · derivative · entry 2 Squires Richard D. · CIK 0001627260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-02-09 F2 · security: Vesting schedule for Options granted 02/09/2016 - Exercise price is $8.60: Options Exerciserable 02/09/2017 - 6,500; Options Exerciserable 02/09/2018 - 6,500; and Options Exerciserable 02/09/2019 - 7,000. Read SEC document |
| February 09, 2016 Filed Nov 9, 2016 20:19 UTC |
HUDSON M ASHTONDirector
|
GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0001209191-16-149027 · doc4.xml · derivative · entry 2 HUDSON M ASHTON · CIK 0001284581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-02-09 F2 · security: Vesting schedule for Options granted 02/09/2016 - Exercise price is $8.60: Options Exerciserable 02/09/2017 - 6,500; Options Exerciserable 02/09/2018 - 6,500; and Options Exerciserable 02/09/2019 - 7,000. Read SEC document |
| February 09, 2016 Filed Feb 16, 2017 19:35 UTC |
Squires Richard D.Director
|
GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0001209191-17-011381 · doc4.xml · derivative · entry 2 Squires Richard D. · CIK 0001627260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-02-09 F2 · security: Vesting schedule for Options granted 02/09/2016 - Exercise price is $8.60: Options Exerciserable 02/09/2017 - 6,500; Options Exerciserable 02/09/2018 - 6,500; and Options Exerciserable 02/09/2019 - 7,000. Read SEC document |
| February 09, 2016 Filed Feb 16, 2017 19:32 UTC |
HUDSON M ASHTONDirector
|
GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0001209191-17-011373 · doc4.xml · derivative · entry 2 HUDSON M ASHTON · CIK 0001284581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-02-09 F2 · security: Vesting schedule for Options granted 02/09/2016 - Exercise price is $8.60: Options Exerciserable 02/09/2017 - 6,500; Options Exerciserable 02/09/2018 - 6,500; and Options Exerciserable 02/09/2019 - 7,000. Read SEC document |
| February 10, 2015 Filed Nov 9, 2016 20:20 UTC |
Silvers Daniel B.Director
|
GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0001209191-16-149031 · doc4.xml · derivative · entry 3 Silvers Daniel B. · CIK 0001468195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-02-10 F3 · security: Vesting schedule for Options granted 02/10/2015 - Exercise price is $14.08: Options Exerciserable 02/10/2016 - 6,500; Options Exerciserable 02/10/2017 - 6,500; and Options Exerciserable 02/10/2018 - 7,000. Read SEC document |
| February 10, 2015 Filed Feb 16, 2017 19:33 UTC |
Silvers Daniel B.Director
|
GrantOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $14.08 | $0.00 |
DisclosureSEC source: 0001209191-17-011379 · doc4.xml · derivative · entry 3 Silvers Daniel B. · CIK 0001468195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-02-10 F3 · security: Vesting schedule for Options granted 02/10/2015 - Exercise price is $14.08: Options Exerciserable 02/10/2016 - 6,500; Options Exerciserable 02/10/2017 - 6,500; and Options Exerciserable 02/10/2018 - 7,000. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.